Vignali Sheila, Buhner Sabine, Greiter Wolfgang, Daniel Hannelore, Frieling Thomas, Schemann Michael, Annahazi Anita
Chair of Human Biology, Technical University of Munich, Freising, Germany.
Chair of Zoology, Technical University of Munich, Freising, Germany.
Front Neurosci. 2024 Jul 2;18:1291554. doi: 10.3389/fnins.2024.1291554. eCollection 2024.
We previously showed enteric nerve activation after application of colonic mucosal biopsy supernatants from patients with irritable bowel syndrome (IBS). The question remains whether this is a region-specific or a generalized sensitization. We tested the nerve-activating properties of supernatants from large and small intestinal regions of IBS patients with diarrhea (IBS-D) in comparison to those from mastocytosis patients with diarrhea (MC-D) or non-IBS/non-MC patients with GI-complaints. MC-D patients were included to test samples from patients with an established, severe mast cell disorder, because mast cells are suggested to play a role in IBS.
Voltage-sensitive dye imaging was used to record the effects of mucosal biopsy supernatants from IBS-D, MC-D, and non-IBS/non-MC on guinea pig submucous neurons. Mast cell density and histamine concentrations were measured in all samples.
The median neuroindex (spike frequency × % responding neurons in Hz × %) was significantly (all < 0.001) increased for IBS-D (duodenum and colon, proximal and distal each, 49.3; 50.5; 63.7; 71.9, respectively) compared to non-IBS/non-MC (duodenum and colon, proximal and distal each, 8.7; 4.9; 6.9; 5.4, respectively) or MC-D supernatants (duodenum and colon, proximal and distal each, 9.4; 11.9; 0.0; 7.9, respectively). Nerve activation by MC-D and non-IBS/non-MC supernatants was comparable (>0.05). Mast cell density or histamine concentrations were not different between IBS-D, MC-D, and non-IBS/non-MC samples.
Nerve activation by biopsy supernatants is an IBS hallmark that occurs throughout the gut, unrelated to mast cell density or histamine concentration. At least as important is our finding that GI complaints were not associated with biopsy supernatant-induced nerve activation, which further stresses the relevance of altered nerve behavior in IBS.
我们之前发现,应用肠易激综合征(IBS)患者的结肠黏膜活检上清液后会出现肠神经激活。问题仍然存在,这是区域特异性的还是全身性的致敏反应。我们测试了腹泻型IBS(IBS-D)患者小肠和大肠区域上清液的神经激活特性,并与腹泻型肥大细胞增多症(MC-D)患者或有胃肠道不适的非IBS/非MC患者的上清液进行比较。纳入MC-D患者以测试来自已确诊的严重肥大细胞疾病患者的样本,因为肥大细胞被认为在IBS中起作用。
使用电压敏感染料成像记录IBS-D、MC-D和非IBS/非MC患者黏膜活检上清液对豚鼠黏膜下神经元的影响。测量所有样本中的肥大细胞密度和组胺浓度。
与非IBS/非MC患者(十二指肠和结肠,近端和远端,分别为8.7;4.9;6.9;5.4)或MC-D患者上清液(十二指肠和结肠,近端和远端,分别为9.4;11.9;0.0;7.9)相比,IBS-D患者(十二指肠和结肠,近端和远端,分别为49.3;50.5;63.7;71.9)的中位神经指数(峰值频率×反应神经元百分比,单位为Hz×%)显著升高(均P<0.001)。MC-D患者和非IBS/非MC患者上清液引起的神经激活相当(P>0.05)。IBS-D、MC-D和非IBS/非MC样本之间的肥大细胞密度或组胺浓度没有差异。
活检上清液引起的神经激活是IBS的一个标志,在整个肠道中都会出现,与肥大细胞密度或组胺浓度无关。同样重要的是,我们发现胃肠道不适与活检上清液诱导的神经激活无关,这进一步强调了IBS中神经行为改变的相关性。